11 décembre 2017
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
11 décembre 2017
SCOR is a signatory of the French Business Climate Pledge, through which 89 French companies commit to taking concrete action to drastically reduce greenhouse gas emissions.
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
6 décembre 2017
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
Presentation of Daria Ossipova about “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Annual Conference SCOR.
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Paolo De Martin's presentation at the Pacific Insurance Conference 2017
4 décembre 2017
SCOR is driven to see its clients succeed and puts all its passion and energy into unlocking value for them.
30 novembre 2017
Antimicrobial resistance is a global concern that can jeopardize the treatment of infectious diseases.
28 novembre 2017
During his presentation at the SCOR Conference 2017, titled “Transhumanism: the future impact of advanced technologies on society and on the insurance industry”, Laurent Alexandre, CEO of DNA Vision, warned insurers o
Si la prévalence des valvulopathies est faible dans la population générale, autour de 2,5 %, elle est beaucoup plus élevée chez les patients âgés de plus de 75 ans, atteignant alors 10 à 15 %.
